Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2004
03/10/2004CN1480139A Local medical compsn contg cholinergic medicine or calcium passage retardant
03/10/2004CN1480134A Combination of iodine amino acid as well as its preparation method and application
03/10/2004CN1480129A Ground substance and plaster of Chinese traditional medicine as well as its preparing method
03/10/2004CN1480128A Preparation of transparent, cryptomorphic external remedy
03/10/2004CN1141297C Process for preparing amlodiping benzenesulphonate
03/09/2004US6703488 Use for intracellular delivery of drugs or other agents for diagnosis and therapy of malignancies or immune-mediated or inflammatory conditions providing rapid, efficient internal-ization of the cytokine receptor antibody/antigen complexes
03/09/2004US6703482 Isolated from three phage-displayed random peptide libraries which had been screened for isolates that bind to bacterial fusion proteins comprising sh3 and glutathione s-transferase (gst).
03/09/2004US6703424 Dispersible compositions containing L-DOPA ethyl ester
03/09/2004US6703417 Improved bioavailability; anticarcinogenic
03/09/2004US6703381 Administering amphiphilic enkephalin-oligomer conjugate
03/09/2004US6703371 Preparations for reducing oxygen consumption during physical efforts
03/09/2004US6703369 Lipase inhibiting compositions
03/09/2004US6703365 Glucagon-like insulinotropic peptides, compositions and methods
03/09/2004US6703050 Methods and compositions for the prevention or treatment of cancer
03/09/2004US6703047 Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
03/09/2004US6703046 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use
03/09/2004US6703040 Polymer impregnated with bactericide, bacteriphage or antibiotic
03/09/2004US6703039 Reversible gelling system for ocular drug delivery
03/09/2004US6703037 Biodegradable macromers for the controlled release of biologically active substances
03/09/2004US6703030 Comprising a carboxylated, acidic amino acid obtained by acidifying an acidic amino acid with a carboxylic acid and a carrier; nonirritating
03/09/2004US6703029 Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type
03/09/2004US6703020 Antibody conjugate methods for selectively inhibiting VEGF
03/09/2004US6702997 Premeasured single unit dose; may be free of anti-microbial preservatives, such as benzalkonium chloride.
03/09/2004US6702995 Delivery system
03/09/2004CA2408198C Pharmaceutical composition comprising cefuroxime axetil
03/09/2004CA2268868C Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
03/09/2004CA2260992C Eye treatments using synthetic thyroid hormone compositions
03/09/2004CA2052229C Antifungal composition in a dry powdered spray form
03/04/2004WO2004018681A2 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof
03/04/2004WO2004018519A2 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor
03/04/2004WO2004018511A2 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins
03/04/2004WO2004018468A2 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments
03/04/2004WO2004018444A1 Clathrates of butylphtualide with cyclodextrin or its derivatives, a process for their preparations and the use there of
03/04/2004WO2004018360A1 Methods and compounds for controlling the morphology and shrinkage of silica derived from polyol-modified silanes
03/04/2004WO2004018312A1 Injectable pharmaceutical suspension in a two-chamber vial
03/04/2004WO2004018066A2 Aqueous two-phase systems for particle manipulation and encapsulation within microscopic volumes
03/04/2004WO2004018025A1 Pharmaceutical compositions
03/04/2004WO2004018010A2 Methods of drug delivery using sulphated chitinous polymers
03/04/2004WO2004018001A1 Polyamine conjugates with acidic retinoids and preparation thereof
03/04/2004WO2004018000A2 Compositions and methods for treating cancer using maytansinoid cd44 antibody immonoconjugates and chemotherapeutic agents
03/04/2004WO2004017999A1 Non-glycosylated polyacrylamide conjugates and their use for cytoprotection
03/04/2004WO2004017998A2 Topical emulsion- gel composition comprising diclofenac sodium
03/04/2004WO2004017975A1 Stable aqueous solutions of risperidone and methods for their preparation
03/04/2004WO2004017962A2 Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region
03/04/2004WO2004017943A2 Non-vesicular cationic lipid formulations
03/04/2004WO2004017937A1 Biodegradable composition with prolonged release of the biological active compound and preparation thereof
03/04/2004WO2004017914A2 Inhalation composition
03/04/2004WO2004017907A2 Blood clot-targeted nanoparticles
03/04/2004WO2004017904A2 Corticosteroid conjugates and uses thereof
03/04/2004WO2004017903A2 Methods for treating fungal infections
03/04/2004WO2004017897A2 Aripiprazole complex formulation and method
03/04/2004WO2004017895A2 Formaldehyde-ammonium salt complexes for the stabilization of blood cells
03/04/2004WO2004017810A2 Tumor specific oligosaccharide epitopes and use thereof
03/04/2004WO2003105908A9 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
03/04/2004WO2003101427A8 Immunoliposomes formed with aggregated antibody
03/04/2004WO2003079993A3 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION
03/04/2004WO2003072143A9 Compositions for delivery of therapeutics and other materials, and methods of making and using the same
03/04/2004WO2003070755A3 Compounds, compositions and method for transporting cyclosporin molecules through the blood brain barrier
03/04/2004WO2003062372A3 Nanoparticle assembled hollow spheres
03/04/2004WO2003060076A3 Povidone-containing carriers for polypeptide growth factors
03/04/2004WO2003057716A3 Dendritic encapsulation of active agents
03/04/2004WO2003055442A3 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)
03/04/2004WO2003053463A3 Poxvirus-containing compositions and process for their preparation
03/04/2004WO2003051286A3 Hydrogel compositions, devices, and microscale components
03/04/2004WO2003048207A3 Anti-dota antibody
03/04/2004WO2003043574A3 Pharmaceutical compositions in particulate form
03/04/2004WO2003039225A3 Antigen arrays comprising rankl for treatment of bone disease
03/04/2004WO2003033025A3 Cyclodextrin complexes
03/04/2004WO2003032904A3 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi)
03/04/2004WO2003026629A3 Modified release dosage forms
03/04/2004WO2003026581A3 Pharmaceutical compositions and methods for treating cancer
03/04/2004WO2003015759A3 Treatment of hyperproliferative conditions of body surfaces
03/04/2004WO2003005961A3 A controlled release biodegradable gel matrix
03/04/2004WO2003002243A3 Method and device for electrochemical formation of therapeutic species in vivo
03/04/2004WO2003002136A3 Stable formulation of modified glp-1
03/04/2004WO2002085248A3 Prostanoids augment ocular drug penetration
03/04/2004WO2002078623A3 Uses of targeted oxidative therapeutic formulation in arteriosclerosis
03/04/2004WO2002072606A3 Epitope testing using hla
03/04/2004WO2002047664A8 Microparticles with an improved release profile and method for the production thereof
03/04/2004WO2002022134A8 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals
03/04/2004WO2002020762A8 Tnf receptor-like molecules and uses thereof
03/04/2004WO2002015938A8 Testosterone ester formulation for human use
03/04/2004US20040044408 Cell-culture and polymer constructs
03/04/2004US20040044241 Novel succinate salt of O-desmethyl-venlafaxine
03/04/2004US20040044178 Hepatotropic conjugates of antiblastic drugs accomplishing a loco-regional chemotherapy of liver micrometastases after adminstration by peripheral venous route
03/04/2004US20040044125 Therapeutic AZO-compounds for drug delivery
03/04/2004US20040044086 Gel composition and trans-scrotal application of a composition for the treatment of hypogonadism
03/04/2004US20040044076 Neutrophil imaging methods in cystic fibrosis
03/04/2004US20040044070 Cardiovascular disorders; antiarrhythmia agents
03/04/2004US20040044035 Antiallergens; rhinitis
03/04/2004US20040044018 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor
03/04/2004US20040043980 Bactericides; storage stability
03/04/2004US20040043964 Cellulosic particle for pharmaceuticals preparation
03/04/2004US20040043963 Complex of chitosan, conjugated linoleic acid, vitamin a and cyclodextrin
03/04/2004US20040043952 Complex of lipid and pentaerythritol; supplying nucleic acids to cells; transfection cells; drug delivery
03/04/2004US20040043949 Therapeutic system targeting pathogen proteases and uses thereof
03/04/2004US20040043939 Peptide-based gemini compounds
03/04/2004US20040043933 Mixture with pH moderator, antioxidant and Group 2a salt; anticoagulant
03/04/2004US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders
03/04/2004US20040043925 Cyclic depsipeptides; veterinary medicine